Colleen McElroy is a member of  DLA Piper's Litigation Practice Group and the firm's FDA and Medical Products Regulatory team, with a particular focus on representing pharmaceutical and medical device manufacturers, and other life sciences companies in litigation and regulatory enforcement matters arising from government investigations, internal compliance audits, product liability claims, and related issues.

Her experience includes representation of clients in Qui Tam (whistleblower) and other litigation with respect to alleged violations of the Federal Food, Drug and Cosmetic Act, the False Claims Act and related state laws, U.S. health care (fraud and abuse) laws, FDA regulations, the Foreign Corrupt Practices Act, and internal corporate policies.